Vistra completes $1.5 billion junior subordinated notes offering
Bitget2026/09/24 21:14- Vistra priced a USD 1.5 billion dual-tranche offering of junior subordinated notes due 2057.
- Deal closed Sept. 24, 2026 through Vistra Operations with an irrevocable, unconditional guarantee from the parent.
- Tranches comprised USD 850 million 7.000% Series A Junior Subordinated Notes due 2057.
- Second tranche totaled USD 650 million 7.250% Series B Junior Subordinated Notes due 2057.
- Barclays, BofA Securities, Mizuho, MUFG, Truist acted as lead underwriters.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uncertainty clouds the US stock IPO market as smart ring manufacturer Oura (OURA.US) joins the ranks of delayed listings
Oura (OURA.US) has become the latest company to postpone its initial public offering (IPO) in the United States due to market uncertainty.
Iovance Biotherapeutics Raises 2026 Revenue Guidance
AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation
Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.
Crypto prices
More
